Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 42Sarcoma 1Head & Neck 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Carcinoma, Transitional Cell 10Carcinoma, Non-Small-Cell Lung 8Urinary Bladder Neoplasms 6Neoplasm Metastasis 6Prostatic Neoplasms 5Melanoma 5Lung Neoplasms 5Carcinoma, Renal Cell 5Ovarian Neoplasms 4Urologic Neoplasms 3Stomach Neoplasms 3Head and Neck Neoplasms 3Colorectal Neoplasms 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Mesothelioma 2Hypopharyngeal Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Thymus Neoplasms 1Thymoma 1Sarcoma 1Salivary Gland Neoplasms 1Recurrence 1Oropharyngeal Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms, Glandular and Epithelial 1

Interventions

pembrolizumab 3tislelizumab 1spartalizumab 1milademetan 1enzalutamide 1devimistat 1dehydroftorafur 1Tablets 1Specimen Handling 1Solutions 1Rogaratinib 1Pemetrexed 1Midazolam 1Magnetic Resonance Spectroscopy 1Letrozole 1IFL protocol 1Hydroxychloroquine 1Gemcitabine 1Fulvestrant 1Fluorouracil 1Cetuximab 1Carboplatin 1BID protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × Pemetrexed × Genitourinary × Clear all
NCT04452214 2023-07-14

A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors

Cantargia AB

Phase 1 Completed
19 enrolled
DermatologicGenitourinaryHead & NeckThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡